Copyright Reports & Markets. All rights reserved.

Global Plasma Therapy Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Plasma Therapy by Type
    • 1.3.1 Overview: Global Plasma Therapy Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Plasma Therapy Consumption Value Market Share by Type in 2025
    • 1.3.3 Pure PRP
    • 1.3.4 Leucocyte-rich PRP
    • 1.3.5 Leukocyte-rich Fibrin (L-PRF)
  • 1.4 Global Plasma Therapy Market by Application
    • 1.4.1 Overview: Global Plasma Therapy Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Orthopedic
    • 1.4.3 Darmatology
    • 1.4.4 Cardiac Muscle Injury
    • 1.4.5 Dental
    • 1.4.6 Nerve Injury
  • 1.5 Global Plasma Therapy Market Size & Forecast
  • 1.6 Global Plasma Therapy Market Size and Forecast by Region
    • 1.6.1 Global Plasma Therapy Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Plasma Therapy Market Size by Region, (2021-2032)
    • 1.6.3 North America Plasma Therapy Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Plasma Therapy Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Plasma Therapy Market Size and Prospect (2021-2032)
    • 1.6.6 South America Plasma Therapy Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Plasma Therapy Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Terumo
    • 2.1.1 Terumo Details
    • 2.1.2 Terumo Major Business
    • 2.1.3 Terumo Plasma Therapy Product and Solutions
    • 2.1.4 Terumo Plasma Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Terumo Recent Developments and Future Plans
  • 2.2 Arthrex
    • 2.2.1 Arthrex Details
    • 2.2.2 Arthrex Major Business
    • 2.2.3 Arthrex Plasma Therapy Product and Solutions
    • 2.2.4 Arthrex Plasma Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Arthrex Recent Developments and Future Plans
  • 2.3 Zimmer Biomet
    • 2.3.1 Zimmer Biomet Details
    • 2.3.2 Zimmer Biomet Major Business
    • 2.3.3 Zimmer Biomet Plasma Therapy Product and Solutions
    • 2.3.4 Zimmer Biomet Plasma Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Zimmer Biomet Recent Developments and Future Plans
  • 2.4 DePuy Synthes
    • 2.4.1 DePuy Synthes Details
    • 2.4.2 DePuy Synthes Major Business
    • 2.4.3 DePuy Synthes Plasma Therapy Product and Solutions
    • 2.4.4 DePuy Synthes Plasma Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 DePuy Synthes Recent Developments and Future Plans
  • 2.5 EmCyte
    • 2.5.1 EmCyte Details
    • 2.5.2 EmCyte Major Business
    • 2.5.3 EmCyte Plasma Therapy Product and Solutions
    • 2.5.4 EmCyte Plasma Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 EmCyte Recent Developments and Future Plans
  • 2.6 Regen Lab
    • 2.6.1 Regen Lab Details
    • 2.6.2 Regen Lab Major Business
    • 2.6.3 Regen Lab Plasma Therapy Product and Solutions
    • 2.6.4 Regen Lab Plasma Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Regen Lab Recent Developments and Future Plans
  • 2.7 ISTO Biologics
    • 2.7.1 ISTO Biologics Details
    • 2.7.2 ISTO Biologics Major Business
    • 2.7.3 ISTO Biologics Plasma Therapy Product and Solutions
    • 2.7.4 ISTO Biologics Plasma Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 ISTO Biologics Recent Developments and Future Plans
  • 2.8 Cesca Therapeutics
    • 2.8.1 Cesca Therapeutics Details
    • 2.8.2 Cesca Therapeutics Major Business
    • 2.8.3 Cesca Therapeutics Plasma Therapy Product and Solutions
    • 2.8.4 Cesca Therapeutics Plasma Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Cesca Therapeutics Recent Developments and Future Plans
  • 2.9 Weigao
    • 2.9.1 Weigao Details
    • 2.9.2 Weigao Major Business
    • 2.9.3 Weigao Plasma Therapy Product and Solutions
    • 2.9.4 Weigao Plasma Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Weigao Recent Developments and Future Plans
  • 2.10 REV-MED
    • 2.10.1 REV-MED Details
    • 2.10.2 REV-MED Major Business
    • 2.10.3 REV-MED Plasma Therapy Product and Solutions
    • 2.10.4 REV-MED Plasma Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 REV-MED Recent Developments and Future Plans
  • 2.11 Nuo Therapeutics
    • 2.11.1 Nuo Therapeutics Details
    • 2.11.2 Nuo Therapeutics Major Business
    • 2.11.3 Nuo Therapeutics Plasma Therapy Product and Solutions
    • 2.11.4 Nuo Therapeutics Plasma Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Nuo Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Plasma Therapy Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Plasma Therapy by Company Revenue
    • 3.2.2 Top 3 Plasma Therapy Players Market Share in 2025
    • 3.2.3 Top 6 Plasma Therapy Players Market Share in 2025
  • 3.3 Plasma Therapy Market: Overall Company Footprint Analysis
    • 3.3.1 Plasma Therapy Market: Region Footprint
    • 3.3.2 Plasma Therapy Market: Company Product Type Footprint
    • 3.3.3 Plasma Therapy Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Plasma Therapy Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Plasma Therapy Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Plasma Therapy Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Plasma Therapy Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Plasma Therapy Consumption Value by Type (2021-2032)
  • 6.2 North America Plasma Therapy Market Size by Application (2021-2032)
  • 6.3 North America Plasma Therapy Market Size by Country
    • 6.3.1 North America Plasma Therapy Consumption Value by Country (2021-2032)
    • 6.3.2 United States Plasma Therapy Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Plasma Therapy Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Plasma Therapy Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Plasma Therapy Consumption Value by Type (2021-2032)
  • 7.2 Europe Plasma Therapy Consumption Value by Application (2021-2032)
  • 7.3 Europe Plasma Therapy Market Size by Country
    • 7.3.1 Europe Plasma Therapy Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Plasma Therapy Market Size and Forecast (2021-2032)
    • 7.3.3 France Plasma Therapy Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Plasma Therapy Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Plasma Therapy Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Plasma Therapy Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Plasma Therapy Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Plasma Therapy Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Plasma Therapy Market Size by Region
    • 8.3.1 Asia-Pacific Plasma Therapy Consumption Value by Region (2021-2032)
    • 8.3.2 China Plasma Therapy Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Plasma Therapy Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Plasma Therapy Market Size and Forecast (2021-2032)
    • 8.3.5 India Plasma Therapy Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Plasma Therapy Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Plasma Therapy Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Plasma Therapy Consumption Value by Type (2021-2032)
  • 9.2 South America Plasma Therapy Consumption Value by Application (2021-2032)
  • 9.3 South America Plasma Therapy Market Size by Country
    • 9.3.1 South America Plasma Therapy Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Plasma Therapy Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Plasma Therapy Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Plasma Therapy Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Plasma Therapy Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Plasma Therapy Market Size by Country
    • 10.3.1 Middle East & Africa Plasma Therapy Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Plasma Therapy Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Plasma Therapy Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Plasma Therapy Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Plasma Therapy Market Drivers
  • 11.2 Plasma Therapy Market Restraints
  • 11.3 Plasma Therapy Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Plasma Therapy Industry Chain
  • 12.2 Plasma Therapy Upstream Analysis
  • 12.3 Plasma Therapy Midstream Analysis
  • 12.4 Plasma Therapy Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Plasma Therapy market size was valued at US$ 368 million in 2025 and is forecast to a readjusted size of US$ 701 million by 2032 with a CAGR of 9.8% during review period.
    Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.
    North America is the largest consumption place, with a consumption market share nearly 53% . Europe is the second largest consumption place with the consumption market share of 26%. Terumo, Arthrex, Zimmer Biomet, DePuy Synthes and EmCyte are the leaders of the industry, top 3 companies occupied about 55% market share.
    This report is a detailed and comprehensive analysis for global Plasma Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Plasma Therapy market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Plasma Therapy market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Plasma Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Plasma Therapy market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Plasma Therapy
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Plasma Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Terumo, Arthrex, Zimmer Biomet, DePuy Synthes, EmCyte, Regen Lab, ISTO Biologics, Cesca Therapeutics, Weigao, REV-MED, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Plasma Therapy market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Pure PRP
    Leucocyte-rich PRP
    Leukocyte-rich Fibrin (L-PRF)
    Market segment by Application
    Orthopedic
    Darmatology
    Cardiac Muscle Injury
    Dental
    Nerve Injury
    Market segment by players, this report covers
    Terumo
    Arthrex
    Zimmer Biomet
    DePuy Synthes
    EmCyte
    Regen Lab
    ISTO Biologics
    Cesca Therapeutics
    Weigao
    REV-MED
    Nuo Therapeutics
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Plasma Therapy product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Plasma Therapy, with revenue, gross margin, and global market share of Plasma Therapy from 2021 to 2026.
    Chapter 3, the Plasma Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Plasma Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Plasma Therapy.
    Chapter 13, to describe Plasma Therapy research findings and conclusion.

    Buy now